With all the fancy predictive analytics that firms have adopted in recent years, why are they still slow to respond once they know a disruption is coming down the line?
GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both food and pharma supply chains.
In the lead-up to July's joint review of the USMCA, companies are left to wonder if a full withdrawal from the deal is actually on the table for the U.S.
Retailers could get whiplash trying to keep up with youthful consumer spending habits, but they better get good at it as the upcoming generations emerge as mature consumers.